HopeStage
Back to all studies
CompletedNCT00864123

D-cycloserine added to CBT for children with OCD

About this titleRead the official source — NCT00864123
Medication studyAges 8–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 8 years to 17 years.

Listed locations
St. PetersburgSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2008
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
University of South Florida
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 8 Years to 17 Years
Official registry ID
NCT00864123
Official title
Show the full official title

D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St. Petersburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of South Florida, a university.

Did this study involve medication?

Yes. The study involved medication, including D-cycloserine and Placebo pill.

Who was this study for?

Listed age limits: 8 years to 17 years.

Want to explore more studies?

Explore studies